MicroPort Endovascular MedTech Ltd (688016) — Working Capital to Net Assets Ratio
MicroPort Endovascular MedTech Ltd (688016) has a Working Capital to Net Assets ratio of 59.5% as of March 2026. Working capital of CN¥2.52 Billion (current assets of CN¥2.95 Billion minus current liabilities of CN¥424.69 Million) is measured against net assets of CN¥4.24 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See how leveraged is MicroPort Endovascular MedTech Ltd's balance sheet to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
MicroPort Endovascular MedTech Ltd Working Capital to Net Assets (2016–2025)
This chart shows how MicroPort Endovascular MedTech Ltd's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of March 2026, the ratio stands at 59.5%, reflecting working capital of CN¥2.52 Billion against net assets of CN¥4.24 Billion CNY. Check MicroPort Endovascular MedTech Ltd (688016) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for MicroPort Endovascular MedTech Ltd (2016–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for MicroPort Endovascular MedTech Ltd from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of MicroPort Endovascular MedTech Ltd.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 27.7% | CN¥2.39 Billion | CN¥8.62 Billion | CN¥2.80 Billion | CN¥409.25 Million | ▼ -35.1 pp |
| 2024 | 62.8% | CN¥2.40 Billion | CN¥3.82 Billion | CN¥2.74 Billion | CN¥339.04 Million | ▼ -16.2 pp |
| 2023 | 79.0% | CN¥3.05 Billion | CN¥3.86 Billion | CN¥3.37 Billion | CN¥312.76 Million | ▲ +15.5 pp |
| 2022 | 63.6% | CN¥1.11 Billion | CN¥1.74 Billion | CN¥1.29 Billion | CN¥186.83 Million | ▼ -21.6 pp |
| 2021 | 85.2% | CN¥1.30 Billion | CN¥1.52 Billion | CN¥1.46 Billion | CN¥162.05 Million | ▼ -2.5 pp |
| 2020 | 87.7% | CN¥1.08 Billion | CN¥1.23 Billion | CN¥1.20 Billion | CN¥114.66 Million | ▲ +1.4 pp |
| 2019 | 86.3% | CN¥920.27 Million | CN¥1.07 Billion | CN¥990.35 Million | CN¥70.08 Million | ▲ +50.8 pp |
| 2018 | 35.5% | CN¥76.84 Million | CN¥216.16 Million | CN¥116.03 Million | CN¥39.20 Million | ▲ +2.0 pp |
| 2017 | 33.5% | CN¥63.02 Million | CN¥188.02 Million | CN¥88.47 Million | CN¥25.45 Million | ▲ +19.7 pp |
| 2016 | 13.8% | CN¥16.99 Million | CN¥123.38 Million | CN¥76.13 Million | CN¥59.14 Million | — |